These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease. Park H; Yoon EL; Ito T; Jo AJ; Kim M; Lee J; Kim HL; Arai T; Atsukawa M; Kawanaka M; Toyoda H; Ishigami M; Yu ML; Jun DW; Nguyen MH JAMA Netw Open; 2023 Aug; 6(8):e2329568. PubMed ID: 37589973 [TBL] [Abstract][Full Text] [Related]
7. Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease. Xun YH; Fan JG; Zang GQ; Liu H; Jiang YM; Xiang J; Huang Q; Shi JP J Dig Dis; 2012 Nov; 13(11):588-95. PubMed ID: 23107446 [TBL] [Abstract][Full Text] [Related]
8. Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes. Pennisi G; Enea M; Falco V; Aithal GP; Palaniyappan N; Yilmaz Y; Boursier J; Cassinotto C; de Lédinghen V; Chan WK; Mahadeva S; Eddowes P; Newsome P; Karlas T; Wiegand J; Wong VW; Schattenberg JM; Labenz C; Kim W; Lee MS; Lupsor-Platon M; Cobbold JFL; Fan JG; Shen F; Staufer K; Trauner M; Stauber R; Nakajima A; Yoneda M; Bugianesi E; Younes R; Gaia S; Zheng MH; Cammà C; Anstee QM; Mózes FE; Pavlides M; Petta S Hepatology; 2023 Jul; 78(1):195-211. PubMed ID: 36924031 [TBL] [Abstract][Full Text] [Related]
9. Advanced liver fibrosis and the metabolic syndrome in a primary care setting. Schreiner AD; Zhang J; Durkalski-Mauldin V; Livingston S; Marsden J; Bian J; Mauldin PD; Moran WP; Rockey DC Diabetes Metab Res Rev; 2021 Nov; 37(8):e3452. PubMed ID: 33759300 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of non-invasive liver fibrosis risk scores in biopsy-proven non-alcoholic fatty liver disease patients in India. Prasad M; Gupta S; Kashyap N; Kapil U Indian J Gastroenterol; 2023 Apr; 42(2):192-198. PubMed ID: 37191918 [TBL] [Abstract][Full Text] [Related]
11. Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients. Ito T; Nguyen VH; Tanaka T; Park H; Yeh ML; Kawanaka M; Arai T; Atsukawa M; Yoon EL; Tsai PC; Toyoda H; Huang JF; Henry L; Jun DW; Yu ML; Ishigami M; Nguyen MH; Cheung RC Clin Gastroenterol Hepatol; 2023 Apr; 21(4):1013-1022.e6. PubMed ID: 35654298 [TBL] [Abstract][Full Text] [Related]
12. Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis. Ampuero J; Pais R; Aller R; Gallego-Durán R; Crespo J; García-Monzón C; Boursier J; Vilar E; Petta S; Zheng MH; Escudero D; Calleja JL; Aspichueta P; Diago M; Rosales JM; Caballería J; Gómez-Camarero J; Lo Iacono O; Benlloch S; Albillos A; Turnes J; Banales JM; Ratziu V; Romero-Gómez M; Clin Gastroenterol Hepatol; 2020 Jan; 18(1):216-225.e5. PubMed ID: 31195161 [TBL] [Abstract][Full Text] [Related]
13. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease. Joo SK; Kim W; Kim D; Kim JH; Oh S; Lee KL; Chang MS; Jung YJ; So YH; Lee MS; Bae JM; Kim BG Liver Int; 2018 Feb; 38(2):331-341. PubMed ID: 28796410 [TBL] [Abstract][Full Text] [Related]
14. Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease. Kaya E; Bakir A; Kani HT; Demirtas CO; Keklikkiran C; Yilmaz Y Gut Liver; 2020 Jul; 14(4):486-491. PubMed ID: 31530739 [TBL] [Abstract][Full Text] [Related]
15. Assessment of liver fibrosis using non-invasive screening tools in individuals with diabetes mellitus and metabolic syndrome. Shaji N; Singhai A; Joshi R J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443467 [TBL] [Abstract][Full Text] [Related]
16. Accuracy of Noninvasive Scoring Systems in Assessing Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Han S; Choi M; Lee B; Lee HW; Kang SH; Cho Y; Ahn SB; Song DS; Jun DW; Lee J; Yoo JJ Gut Liver; 2022 Nov; 16(6):952-963. PubMed ID: 35193993 [TBL] [Abstract][Full Text] [Related]
17. Accuracy of the Enhanced Liver Fibrosis Test in Patients With Type 2 Diabetes Mellitus and Its Clinical Implications. Arai T; Takahashi H; Seko Y; Toyoda H; Hayashi H; Yamaguchi K; Iwaki M; Yoneda M; Shima T; Fujii H; Morishita A; Kawata K; Tomita K; Kawanaka M; Yoshida Y; Ikegami T; Notsumata K; Oeda S; Atsukawa M; Kamada Y; Sumida Y; Fukushima H; Miyoshi E; Aishima S; Okanoue T; Itoh Y; Nakajima A; Clin Gastroenterol Hepatol; 2024 Apr; 22(4):789-797.e8. PubMed ID: 38048934 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage. Siddiqui MS; Yamada G; Vuppalanchi R; Van Natta M; Loomba R; Guy C; Brandman D; Tonascia J; Chalasani N; Neuschwander-Tetri B; Sanyal AJ; Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1877-1885.e5. PubMed ID: 30616027 [TBL] [Abstract][Full Text] [Related]
19. Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease. Huang C; Seah JJ; Tan CK; Kam JW; Tan J; Teo EK; Kwek A; Wong YJ; Tan M; Ang TL; Kumar R Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101528. PubMed ID: 33268036 [TBL] [Abstract][Full Text] [Related]
20. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease. Mansoor S; Yerian L; Kohli R; Xanthakos S; Angulo P; Ling S; Lopez R; Christine CK; Feldstein AE; Alkhouri N Dig Dis Sci; 2015 May; 60(5):1440-7. PubMed ID: 25540086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]